Close
Close

Biogen - Infantile-onset Spinal Muscular Atrophy (SMA)

Partner

Not provided

Rare Disease

Infantile-onset Spinal Muscular Atrophy (SMA)

Sponsor

Biogen

Access Program Information

To provide access to nusinersen to eligible patients with Infantile-onset Spinal Muscular Atrophy (SMA) (consistent with Type 1) to address a high-unmet medical need.

Contact

Contact: Biogen

Locations
  • Australia
  • Austria
  • Belgium
  • Canada
  • Finland
  • France
  • Germany
  • Ireland
  • Israel
  • Italy
  • Norway
  • Poland
  • Portugal
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom

Free Newsletter